Search

Hiroaki Kiyokawa

from Willowbrook, IL
Age ~63
Get Report
Also known as:
Hiroaki Kiokawa, Hiro Kuyokawa, Hiroaki A
Related to:
Yumiko Kiyokawa, 64
Connected to:
Emanuel W Kiyola, 57Colleen M Kiyonaga, 73Spencer C Kiyono, 35Dennis K Kiyota, 62Joanne F Kiyota, 70Keith E Kiyota, 63Tracie A Kiyota, 52Margaret G Kiza, 60Kimberly L Kizak, 56Eric Kizaki, 37

Hiroaki Kiyokawa Phones & Addresses

  • Willowbrook, IL
  • 1552 Fullerton Ave, Chicago, IL 60614 (773) 529-2239
  • 1552 W Fullerton Ave #2, Chicago, IL 60614
  • 21 Chestnut St, Chicago, IL 60610 (312) 643-1105 (312) 664-2846
  • 100 Chestnut St, Chicago, IL 60610
  • Hinsdale, IL
  • Sheboygan, WI
  • New York, NY
  • 21 W Chestnut St APT 1105, Chicago, IL 60610 (312) 315-7254

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: Associate degree or higher

Emails

h***[email protected]

Business Records

Name / Title
Company / Classification
Phones & Addresses
Hiroaki Kiyokawa
Principal
NADA TEA & COFFEE HOUSE LLC
Eating Place
1552 W Fullerton, Chicago, IL 60614
1552 W Fullerton Ave, Chicago, IL 60614
(773) 529-2239

Publications

Us Patents

Induction Of Cellular Senescence By Cdk4 Disruption For Tumor Suppression And Regression

View page
US Patent:
20070275918, Nov 29, 2007
Filed:
May 12, 2004
Appl. No.:
10/577591
Inventors:
Hiroaki Kiyokawa - Chicago IL, US
Xianghong Zou - Columbus OH, US
Assignee:
The Board of Trustees of the University of Illinois - Urbana IL
International Classification:
A61K 31/7105
C07H 21/04
C12N 15/11
US Classification:
514044000, 435375000, 536023100
Abstract:
The invention provides methods of inhibiting growth of tumor cells comprising contacting the cells with a Cdk4 inhibitor. The invention also provides methods of treating patients having, suspected of having, or at a high risk for developing, a cancer, comprising treatment with a Cdk4 inhibitor. The invention also relates to pharmaceutical compositions for treating such patients, wherein the pharmaceutical compositions comprise a Cdk4 inhibitor. The invention further relates to Cdk4 siRNA molecules capable of inhibiting Cdk4 expression or activity.

Methods For Enhancing Animal Growth And Cell Proliferation By Elimination Of The Cyclin-Dependent Kinase Inhibitor Function Of P27Kip1

View page
US Patent:
20030027777, Feb 6, 2003
Filed:
Jan 4, 2002
Appl. No.:
10/038060
Inventors:
Andrew Koff - New York NY, US
Hiroaki Kiyokawa - Chicago IL, US
International Classification:
A61K048/00
C12N015/85
US Classification:
514/044000, 424/093210, 435/455000
Abstract:
This invention provides a recombinant non-human animal lacking the cyclin-dependent kinase inhibitor function of p27and the method for producing the same. This invention also provides a method for increasing the proliferation of the thymic T-cells by treating the thymic T-cells to eliminate the cyclin-dependent kinase inhibition function of p27. This invention also provides a method for increasing the proliferation of hematopoietic cells which comprises treating the hematopoietic cells to eliminate the cyclin-dependent kinase inhibitor function of p27, thereby increasing the proliferation of the hematopoietic cells. This invention further provides a method for alleviating symptoms of an AIDS patient comprising steps of: a) collecting the lymphocytes or other cells from an AIDS patient; b) treating the collected cells to eliminate the cyclin-dependent kinase inhibition function of p27; and c) re-introducing the treated cells to the AIDS patient.
Control profile
Hiroaki Kiyokawa from Willowbrook, IL, age ~63 Get Report